Background: MRI diagnostic criteria have not yet been adopted for pediatric multiple sclerosis
MRI criteria for lesion dissemination and evolution over time within the CNS support the diagnosis of multiple sclerosis (MS) in adults, [1] [2] [3] [4] and play a pivotal role in the design of therapeutic trials. 5, 6 Increasing recognition and treatment of children with MS [7] [8] [9] underscores the urgent need for pediatric-specific MRI diagnostic criteria. We have previously shown that the adult-based MRI lesion distribution criteria are not as sensitive to the MRI appearance of MS in children. 10 This may be due to inherent age-related differences in disease pathology, including limited time for accrual of clinically silent white matter lesions, age-related influences on regional proclivity for lesion distribution, or an enhanced reparative capacity in children limiting residual lesion burden.
In addition, diagnostic criteria for MS in children should be designed to exclude nondemyelinating relapsing neurologic disorders relevant to the pediatric population, such as migraine and systemic lupus erythematosus. Differentiation of MS from other acquired inflammatory demyelinating disorders, such as acute disseminated encephalomyelitis (ADEM), is also critical-this important issue is the subject of the companion article. 11 We quantify and compare lesion number, size, and distribution (lesion dissemination in space) in children with MS and compare these features to those from children with other nondemyelinating neurologic diseases (OND), and propose sensitive and specific MRI diagnostic criteria for pediatric MS.
METHODS Pediatric MS cohorts. We performed a retrospective analysis of MR images acquired between September 1994 and December 2003 from all children with clinically definite MS (CDMS) followed prospectively in the Demyelinating Disease program at The Hospital for Sick Children in Toronto (study cohort). Patients diagnosed with CDMS between January 2004 and July 2006 were combined with patients with CDMS followed at Texas Children's Hospital to create the MS group used for criteria validation (validation cohort).
All pediatric MS participants were under age 18 years at MS diagnosis, defined by two or more demyelinating attacks separated by more than 30 days, 12 and all were required to have axial FLAIR or T2-weighted MR images of adequate quality acquired within 6 months of either the initial demyelinating attack or the second MS-defining clinical event. Of the 43 children identified for the study cohort, one was excluded based on clinical features more consistent with a diagnosis of neuromyelitis optica, 13 and four had inadequate MR images for analyses. Of the remaining 38 patients, 28 had scans available from their initial demyelinating attack, 34 had scans available from their MS-defining clinical event, and 24 had both. All 21 children in the validation cohort met inclusion criteria, and all had images available from their second attack.
OND controls. MRI scans from children diagnosed with migraine (International Headache Society Criteria for Migraine with or without aura) 14 or systemic lupus erythematosus (SLE) 15, 16 with clear documentation of clinical CNS involvement comprised the OND control group. These subjects were ageand sex-matched as a group with the MS study cohort.
Quantitative analysis of MR images. MR images were acquired on 1.5 Tesla magnets with slice thicknesses between 3 and 5 mm and an interslice gap of up to 2.5 mm. All MR images were scored blinded to clinical diagnosis.
Detailed delineation of the lesion characterization technique employed is provided online (see e-Methods on the Neurology ® Web site at www.neurology.org). Briefly, individual lesions were identified on axial T2 and FLAIR images (viewed simultaneously when both available). All lesions were identified and coded for location and measured in their maximum axial diameter. Lesion location was categorized as shown in the figure. Lesions spanning multiple contiguous slices were mapped to their full longitudinal extent on sequential images, and the longitudinal dimension calculated using known slice and interslice dimensions. For each patient, the total number of lesions in each category, as well as the overall total lesion count, was determined. Although each lesion counted only once toward the lesion total, many individual lesions-and essentially all large lesions-contributed to more than one lesion location category.
The number of enhancing lesions was recorded, but since gadolinium enhanced scans were not acquired for all patients, assessment of enhancing lesions was not included in the quantitative analysis. The presence or absence of "black holes" was scored as a dichotomous variable. Lesions were only considered to be black holes if they appeared as hypointense to gray matter on T1-weighted images with a signal intensity similar to CSF, and as bright on T2-weighted images (defined as brighter than the non-T1 hypointense T2 lesions seen on the same image and of a signal intensity similar to CSF). Contrast enhancement of black holes was documented. When available, spinal MRI studies were analyzed to determine total lesion count and number of lesions spanning three or more vertebral segments. Qualitative analysis of MR images. Following the quantitative scoring, axial and sagittal T2 or FLAIR images for all patients were reanalyzed for the presence of 1) KIDMUS criteria, 17 2) revised McDonald criteria, 2 and 3) for evidence of diffuse, bilateral lesions (hazy, ill-defined, bilaterally asymmetric, and large (Ͼ20 mm in either axial or longitudinal dimension).
Statistical analyses. All statistical analyses were performed using SPSS version 12.0.
Sample size calculations. Based on previously published
MRI characteristics (i.e., expected number of T2 hyperintensities) of children with MS, migraine, and systemic lupus erythematosus, 18 -20 a large effect size (0.8) was expected when total lesion counts were compared between groups. Based on this, it was determined that a minimum of 25 patients with MS and OND controls would be required if the ␣ error was set at 0.05, and the ␤ error was set at 0.2.
Comparison of patients with MS and OND controls.
Mean lesion counts for all location and size categories were compared using Student t tests with Bonferroni correction for multiple comparisons. Effect size was measured using Cohen d, 21 whereby the magnitude of the difference (accounting for SD) was defined as small (Ͻ0.5), medium (0.5-0.8), and large (Ͼ0.8). Fisher exact testing was used to compare qualitative categories between groups (also using a Bonferroni correction for multiple comparisons). An overall Bonferroni correction for all tests was not utilized. A forward stepwise conditional logistic regression analysis was used to determine which MRI categories could best separate patients with MS from nondemyelinating controls. Quantitative variables with effect sizes (Cohen d) of 1.2 or greater and all qualitative variables were given the opportunity to enter the regression model (p in Ͻ 0.05, p out Ͼ 0.10). The number of quantitative variables allowed entry was limited to those with the largest effect sizes due to sample size constraints relative to the number of quantitative variables assessed. The threshold of d Ն 1.2 was chosen post hoc as the mean value being Ն88% of that of the control group. The quantitative variables were entered as continuous and linearity assumptions were considered at the onset of analyses. Variables that were identified as significant were then evaluated with respect to the optimal cutpoints. The categories allowed entry to the final regression equation were then used to develop the proposed diagnostic criteria. In order to maximize accuracy, various category combinations and mean lesion count cutoff values (ranging from 0 to 10 lesions for each numeric variable) were evaluated, with the model producing the highest overall accuracy being used.
RESULTS Demographics. No differences were found in gender or age between patients with MS and OND controls (table 1) . Seven children in the MS study group experienced a first demyelinating event consistent with ADEM (as defined by polyfocal features and encephalopathy). 22 All of these children subsequently experienced multiple, non-ADEM like demyelinating attacks leading to their diagnosis of MS.
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Rater reliability. Cohen values for all intrarater and interrater reliability comparisons exceeded 0.80, with the majority greater than 0.95 (table e-1). The exception was delineation of lesions located in the internal capsule (intrarater reliability 0.74, interrater reliability 0.82). This category did not contribute to the final criteria.
MRI appearance of pediatric MS. Table 2 summarizes the mean lesion count and lesion size comparing the MS group at the time of their second MSdefining attack and the OND controls. The number of subjects having at least one lesion in a given lesion location category is represented in table e-2. No differences were found in mean lesion counts between first and second attacks (data not shown). Only two patients failed to show new lesions on the MRI obtained at their second attack (one with optic neuritis, one with unilateral sensory loss). Table 3 summarizes the comparison of qualitative lesion categories between patients with MS at the time of their disease defining attack and the OND controls.
Distinguishing patients with MS from OND controls.
Mean lesion counts of the MS and OND groups were different for all location categories (p Ͻ 0.0026 after correction for multiple comparisons) with the exception of juxtacortical white matter and cortical gray matter. The largest effect sizes (d ϭ 1.4) were observed in deep white matter, periventricular white matter, and brainstem. The regression analysis generated a model ( 2 ϭ 85.417, df ϭ 3, R 2 ϭ 0.887, p Ͻ 0.0001) containing mean lesion counts from periventricular white matter (OR ϭ 4.36, CI ϭ 1.11-17.21, p ϭ 0.035), brainstem (OR ϭ 23.01, CI ϭ 1.13-468.23, p ϭ 0.041), and total mean lesion count (OR ϭ 1.15, CI ϭ 1.01-1.32, p ϭ 0.041). Deep white matter lesions did not emerge as contributory to the model, likely owing to overlap with the periventricular category. Application of the regression model to the MS group from which it was derived resulted in a sensitivity of 88%, a specificity of 98%, a positive predictive value of 97%, and a negative predictive value of 92%.
A variety of cutoff values and "and/or" combinations of the periventricular white matter, brainstem, and mean total lesion count were assessed for sensitivity, specificity, positive predictive value, negative predictive value, and receiver operating curve characteristics. The cutoff values were chosen separately for each variable in order to enhance either specificity or sensitivity (e.g., the cutoff value for total lesion count was set at 2 standard deviations above the mean for the OND controls to maximize specificity [see figure e-1]). The optimal set of parameters to maximize group differentiation was determined to be presence of at least two of 1) Ն5 T2 hyperintense lesions, 2) Ն2 periventricular lesions, or 3) Ն1 brainstem lesion. Application of these criteria to the MS group from which they were generated yielded a sensitivity of 85%, specificity of 98%, positive predictive value of 97%, and a negative predictive value of 90%.
Validation of the proposed criteria. The proposed criteria were applied to MR images (from the second demyelinating attack) of an independent group of 21 pediatric patients with MS (validation cohort). Application of the criteria to MRI scans from the MS validation cohort yielded a sensitivity of 90%.
Comparison of the proposed criteria to published MRI criteria. Table 4 compares the McDonald MRI criteria for dissemination in space designed for adult patients with MS, 2,4 the pediatric MS criteria proposed by the KIDMUS study group, 17 and the criteria generated in the present work for accuracy in both the study and validation pediatric MS cohorts. DISCUSSION We provide a systematic quantitative characterization of the MRI appearance of pediatric MS. While computer-based lesion analysis on research-quality standardized images would perhaps have provided even greater lesion recognition, such analyses would not address our primary objective, which was to create a scoring tool applicable in a clinical setting. In addition to defining lesion number and distribution in children with MS, we also employed the same methodologies to MR images of children with nondemyelinating neurologic disorders in order to develop MRI criteria for the diagnosis of MS in children. The sensitivity of these criteria was further evaluated in an independent cohort of pediatric patients with MS. Based on these results, we propose modifications to current adult-based MRI criteria that will enhance the diagnostic utility of these criteria for pediatric MS. The potential utility of our proposed modifications is supported by the fact that application of the current adult-MS based McDonald criteria for dissemination in space 2,4 to our pediatric MS population (study and validation Table 3 Comparison of qualitative and semiquantitative variables assessed between patients with MS at second attack and OND controls †Of the five patients with MS not meeting the criteria, three had greater than five lesions, but did not have more than two in a periventricular location nor did they have brainstem lesions; one child had more than two periventricular lesions but had fewer than five total lesions and none in the brainstem; and one child had a brainstem lesion, but had fewer than five total lesions and did not have two or more in a periventricular location. ‡Numbers in parentheses represent 95% confidence intervals for application of criteria in original cohort. § Based on McNemar tests comparing the overall accuracy (met criteria vs did not meet criteria) of the given model to that of the proposed pediatric MS model. MS ϭ multiple sclerosis; CDMS ϭ clinically definite MS; OND ϭ other nondemyelinating neurologic diseases; KIDMUS CCϭ lesions perpendicular to the long axis of the corpus callosum.
cohorts) produced a sensitivity of only 76% as compared to the 85% sensitivity of our proposed criteria.
The majority of lesions fell into the "small" category. Of interest, however, 65% of the pediatric patients with MS had at least one large lesion (Ͼ2 cm). The proclivity for large lesions in children with MS has been reported previously. 23, 24 The high lesion count noted at the time of first attack is strikingly similar to that reported at the time of first attack in adult patients with MS (median lesion counts 24 -27) 25,26 and belies the hypothesis that the young age of pediatric patients with MS limits accrual of clinically silent lesions prior to first clinical presentation. Some of the typical lesion patterns seen are displayed in figure e-2.
Integral to our work was strict adherence to proposed international guidelines for the diagnosis of MS, requiring children whose first MS attack resembled ADEM to experience two further non-ADEM attacks, and excluding children meeting guideline criteria for multiphasic or recurrent ADEM. 22 Another integral aspect of our work was the selection of children with CNS lupus and migraine as controls-a population of children with relapsing focal neurologic signs associated with multifocal T2 hyperintense lesions on MRI 19, 27 (see figure e-2). Systemic manifestations of lupus are not always present, and thus MRI evidence of white matter lesions often leads to consideration of MS in this population. White matter lesions in children with migraine, particularly those patients with larger lesions or patients with transient neurologic deficits, may also prompt consideration of MS. Only one of 45 control participants met our proposed MRI criteria for MS. This patient, a 14-year-old boy with lupus, had a total of 14 lesions, two of which were periventricular. Analysis of the specificity of our proposed MRI criteria to other relapsing disorders such as stroke and CNS vasculitis are now underway. We did not select as controls children with inherited white matter diseases, as the progressive nature of these diseases is rarely confused with MS in children. Primary progressive MS occurs exceptionally rarely in childhood. 8 MRI criteria for the diagnosis of MS in children have already been proposed by KIDMUS group. 17 Although the KIDMUS criteria were highly specific for MS (100% specificity), they only identified 30% of our patients with MS at their first clinical event and 47% at the second attack, which fared poorly when compared to the 85% sensitivity of our proposed criteria.
Our proposed MRI criteria for pediatric MS differ from the McDonald MRI criteria for lesion dissemination in space currently used to support the diagnosis of MS in adults. 2, 4 Fewer total T2 lesions (Ն5 vs Ն9) were required to identify children with MS with a high sensitivity (94%). Only 82% of our pediatric MS study population had more than nine lesions. Similarly, although over 90% of children had at least one periventricular lesion, 82% had more than two lesions, while only 65% had three or more. As a result, modification of the criteria to Ն2 lesions in this location was more sensitive for pediatric MS, at the same time as maintaining high specificity. Unlike in adult MS, juxtacortical white matter lesions did not emerge as contributory to the criteria for MS in children, likely owing to the highly variable lesion counts (0 to 147) in this category. Brainstem lesions emerged as a more specific criterion in children than the broad category of infratentorial lesions. This is supported by previous pediatric demyelinating studies that report increased frequency of lesions in the brainstem compared to the cerebellum, 17 and by a recent study by our group in which we document a significant frequency of brainstem lesions in children with acute demyelination. 28 Furthermore, cerebellar lesions were present in the control population, but brainstem lesions were not. Consequently, combining the two categories as "infratentorial" resulted in a model with decreased specificity. Since only a limited number of our patients with MS, and none of our controls, had spinal imaging, we are unable to comment about the use of spinal lesions as contributing to the "infratentorial" category. Gadolinium enhancement was not incorporated into our criteria, as these sequences were not available for all patients. However, in those patients with gadoliniumenhanced scans (n ϭ 16), allowing one enhancing lesion to replace the minimum of Ն5 T2 hyperintense lesions did not alter the sensitivity of our model. Future studies employing the use of gadolinium in children with suspected MS will be of value in determining the frequency and specificity of enhancing lesions at the time of a first demyelinating event. Safety considerations should not preclude the use of gadolinium in children with normal renal and hepatic function.
A key aspect of the McDonald criteria 2,4 not evaluated in the present work is the capacity to utilize serial MRI to confirm disease dissemination in time. Prospective studies are required to evaluate MRI evidence of clinically silent lesion accrual in children following an initial demyelinating event. Given that 94% of our pediatric MS population had MRI evidence of new lesions distinct from those accounting for the clinical features of their second MS attack, it is likely that MRI evidence of dissemination in time will be of similar importance in pediatric MS as it is in the evaluation of adult-onset disease.
